title: Severe ductopenic rejection following liver transplantation: incidence, time of onset, risk factors, treatment, and outcome.
authors.affiliation: Division of Hepatology, Mayo Clinic, Rochester, Minnesota 55905.
authors.forename: B
authors.initials: B
authors.lastname: van Hoek
authors.forename: R H
authors.initials: RH
authors.lastname: Wiesner
authors.forename: R A
authors.initials: RA
authors.lastname: Krom
authors.forename: J
authors.initials: J
authors.lastname: Ludwig
authors.forename: S B
authors.initials: SB
authors.lastname: Moore
mesh_terms: D000328:Adult; D001653:Bile Ducts, Intrahepatic / Q000473:pathology; D001706:Biopsy; D015331:Cohort Studies; D005260:Female; D006084:Graft Rejection; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D016031:Liver Transplantation / Q000276:immunology / Q000473:pathology; D008297:Male; D015999:Multivariate Analysis; D012307:Risk Factors; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents